Annals of Oncology
Publication date:
2014-01-01
Volume:
25
Publisher:
Kluwer Academic Publishers
Author:
Van Cutsem, Eric
Cervantes, A ; Nordlinger, B ; Arnold, D
Keywords:
Science & Technology, Life Sciences & Biomedicine, Oncology, PHASE-III TRIAL, CETUXIMAB PLUS IRINOTECAN, WILD-TYPE KRAS, RESECTABLE LIVER METASTASES, 1ST-LINE TREATMENT, COMBINATION CHEMOTHERAPY, OPEN-LABEL, INFUSIONAL FLUOROURACIL, PANITUMUMAB PLUS, RANDOMIZED-TRIAL, Colorectal Neoplasms, Combined Modality Therapy, Follow-Up Studies, Health Planning Guidelines, Humans, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Societies, Medical, ESMO Guidelines Working Group, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3202 Clinical sciences, 3211 Oncology and carcinogenesis